Close Navigation
Learn more about IBKR accounts

From the eye test to the smell test

Posted December 5, 2023
Patrick J. O’Hare
Briefing.com

The stock market has a big weight on its shoulders. The mega-cap stocks are weak again and that is weighing on the equity futures market.

Currently, the S&P 500 futures are down 14 points and are trading 0.3% below fair value, the Nasdaq 100 futures are down 63 points and are trading 0.4% below fair value, and the Dow Jones Industrial Average futures are down 92 points and are trading 0.3% below fair value.

The mega-cap malaise follows what has been an extraordinary run since late October and, really, all year.

There will be periods like this when a profit-taking inclination kicks in, and when there are, it will be challenging for the major indices to pass the eye test. The question is, can they pass the smell test?

The smell test incorporates the rest of the market and how it does when the mega-cap stocks aren’t doing so well. The rest of the market did just fine yesterday when the mega-cap stocks did not. One could see the rotation in the air, and also smell it.

To that end, the market-cap weighted S&P 500 declined 0.5% on Monday, but the equal-weighted S&P 500 managed a fractional gain.

There is a feeling of thickness in the air today, however, with market participants questioning if stocks in general can keep running like they have. The Equal-Weighted S&P 500 Index has had a parabolic move of its own, surging 12.6% from its October 27 low.

Investor sentiment readings skewing strongly to the bullish side of things have created a bit of a contrarian headwind. The news that Moody’s cut China’s credit outlook to Negative from Stable, due in part to concerns about structurally weaker growth prospects, has also tempered some of the buying interest this morning along with the impending release of the ISM Non-Manufacturing PMI for November (Briefing.com consensus 52.4%; prior 51.8%) and the JOLTS – Job Openings Report for October (Prior 9.553 million) at 10:00 a.m. ET.

Treasury yields are sliding in front of those reports. The 2-yr note yield is down four basis points to 4.61% and the 10-yr note yield is down seven basis points to 4.21%. These lower yields pass the eye test as a good thing, but whether they pass the smell test is another question. If they are moving lower on growth concerns, that will inevitably invite concerns about earnings prospects.

That doesn’t seem to be the prevailing case at the moment, but it is something to keep an eye on and to have a nose for.

Originally Posted December 5, 2023 – From the eye test to the smell test

Join The Conversation

If you have a general question, it may already be covered in our FAQs. If you have an account-specific question or concern, please reach out to Client Services.

One thought on “From the eye test to the smell test”

  • about the smell test, are you referring to John Kerry dropping an environmental air hazard
    at the Climate Summit ? He is on tape, and its been ID as hazardous material ?
    Confused in Phila

Leave a Reply

Your email address will not be published. Required fields are marked *

Disclosure: Interactive Brokers

Information posted on IBKR Campus that is provided by third-parties does NOT constitute a recommendation that you should contract for the services of that third party. Third-party participants who contribute to IBKR Campus are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Briefing.com and is being posted with its permission. The views expressed in this material are solely those of the author and/or Briefing.com and Interactive Brokers is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to buy or sell any security. It should not be construed as research or investment advice or a recommendation to buy, sell or hold any security or commodity. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

IBKR Campus Newsletters

This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.